Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

BHVN was delisted on the 3rd of October, 2022.

• Market cap: $10.9B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.

Employees: 928